Dec 17, 2004
What do you know about R278474?
Has it been presented at any conferences? Why has the media made such a big deal about it?
Response from Dr. Henry
R278474 (also known as DAPYs) is a new compound developed at Rutgers University which inhibitors HIV reverse transciptase. Pre-clinical studies have been positive and I believe the first human studies are being planned. I have not seen in human/clinical data so I cannot comment further. KH
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Burning Feet Peripheral Neuropathy
- How Long Does Diarrhea Last In The Early Stages Of Hiv?
- Is Lower Left Abdominal Pain An Hiv Symptom?
- Antifungal Mouth Rinses Used To Treat Thrush
- Hepatitis B Symptoms Stool Color
- Statistics Of People Contracting Hiv From One Encounter Of Unprotected Sex
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.